APOE and Alzheimer disease: The influence of APOE4 on a person's AD risk, subsequent rate of clinical decline, and differential beneficial and adverse effects of the first AD disease‐modifying medications has begun to have a major impact on the scientific and clinical fight against the disease.12, 13